Erdafitinib,Vinflunine,Docetaxel,Pembrolizumab,enfortumab,cisplatin,carboplatin,gemcitabine
Janssen,pierre fabre,Merck,Astellas,Seagen
['bladder', ' sg ', 'erdafitinib']
so how all 3 options in second line setting for metastatic bladder carcinoma do ? ev, sg and erdafitinib. all 3 are similar. choice depends upon pt characteristics and preferences and toxicity profile #asco23 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists